Pharmacy benefit firm myMatrixx is holding a webinar April 23 to discuss its latest workers’ compensation drug trend report.
The presentation will cover topics such as what’s driving the decline in opioid use that continued in 2019. It will also explore new private-label topical drugs that myMatrixx said are driving up costs with little to no perceivable value for patients.
The presentation will also cover the impacts of generic Lyrica, which myMatrixx said is having a strong impact on reducing spending in the work comp industry. And it will cover the effects of an aging workforc...
Comments